Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Age \> 18 years and ≤ 65 years old.

• American Society of Anesthesiologists (ASA) physical status II-III.

• Body mass index 18-35 kg/m2.

• Patients scheduled for thoracotomies for lung cancer.

Locations
Other Locations
Egypt
Cairo University
RECRUITING
Cairo
Contact Information
Primary
Mai M Elrawas, MD
mai.elrawas@nci.cu.edu.eg
00201222177242
Time Frame
Start Date: 2026-01-24
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 70
Treatments
Experimental: CTFB Group
Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.
Experimental: TPVB Group
Patients will receive an ipsilateral ultrasound-guided thoracic paravertebral plane block with injection of 20 ml bupivacaine 0.25%.
Related Therapeutic Areas
Sponsors
Leads: National Cancer Institute, Egypt

This content was sourced from clinicaltrials.gov